Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy)

Silence Therapeutics (SLN) rated speculative Buy ahead of Aug 2026 divesiran Phase 2 PV catalyst; mRNAi platform may beat rivals.
PsyPost on MSN

More hot yoga means less severe depression symptoms, new trial analysis finds

Attending heated yoga classes provides a proportional reduction in depression severity, meaning that the more sessions a ...

How The Temper Trap’s Dougy Mandagi recovered the voice he feared he’d lost

Dougy Mandagi, 46, is the frontman of ARIA award-winning Melbourne indie rock quartet The Temper Trap. Ahead of the release ...

AI Isn't Killing Education. It's Exposing What Was Already Broken.

AI is transforming education by exposing outdated teaching and assessment, forcing schools to rethink learning, academic ...
Nature

Aims and scope

Scientific Data is an open access journal dedicated to data, publishing descriptions of research datasets and articles on research data sharing from all areas of natural sciences, medicine, ...